CY1106252T1 - Εμβολιο πολλαπλων συστατικων που πepιλαμβανει τουλαχιστον δυο αντιγονα απο haemophilus influenzae για την προστασια εναντι νοσησης - Google Patents

Εμβολιο πολλαπλων συστατικων που πepιλαμβανει τουλαχιστον δυο αντιγονα απο haemophilus influenzae για την προστασια εναντι νοσησης

Info

Publication number
CY1106252T1
CY1106252T1 CY20061101690T CY061101690T CY1106252T1 CY 1106252 T1 CY1106252 T1 CY 1106252T1 CY 20061101690 T CY20061101690 T CY 20061101690T CY 061101690 T CY061101690 T CY 061101690T CY 1106252 T1 CY1106252 T1 CY 1106252T1
Authority
CY
Cyprus
Prior art keywords
haemophilus influenzae
antigens
attaching
protection against
against disease
Prior art date
Application number
CY20061101690T
Other languages
English (en)
Inventor
Sheena M. Loosmore
Yan-Ping Yang
Michel H. Klein
Original Assignee
Sanofi Pasteur Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22785184&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106252(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Pasteur Limited filed Critical Sanofi Pasteur Limited
Publication of CY1106252T1 publication Critical patent/CY1106252T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Ανοσογόνος σύνθεση πολλαπλών συστατικών επιφέρει προστασία σε ανοσοποιημένο ξενιστή έναντι λοίμωξης προκαλούμενης από Haemophilus influenzae. Τέτοια σύνθεση περιλαμβάνει τουλάχιστον δύο διαφορετικά αντιγόνα του Haemophilus influenzae, ένα των οποίων είναι κάποια προσκολλησίνη. Πρωτεΐνες υψηλού μοριακού βάρους (HMW) κάποιου μη τυποποιούμενου Haemophilus influenzae ενισχύουν την ανοσοαπόκριση σε ξενιστή έναντι κάποιου μη πρωτεολυτικού αναλόγου της πρωτεΐνης Hin47 σε τέτοιες ανοσογόνες συνθέσεις με το ένα συστατικό να μη μειώνει την ανοσογονικότητα του άλλου. Το εμβόλιο Haemophilus μπορεί να συνδυαστεί με εμβόλια DTP-συστατικών για την παροχή εμβολίων πολυσθενών συστατικών χωρίς εξασθένηση των ανοσογονικών ιδιοτήτων των άλλων αντιγόνων.
CY20061101690T 1998-12-15 2006-11-21 Εμβολιο πολλαπλων συστατικων που πepιλαμβανει τουλαχιστον δυο αντιγονα απο haemophilus influenzae για την προστασια εναντι νοσησης CY1106252T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/210,995 US6974581B1 (en) 1998-12-15 1998-12-15 Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
PCT/CA1999/001189 WO2000035477A2 (en) 1998-12-15 1999-12-15 Multi-component vaccine comprising at least two antigens from haemophilus influenzae

Publications (1)

Publication Number Publication Date
CY1106252T1 true CY1106252T1 (el) 2011-06-08

Family

ID=22785184

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101690T CY1106252T1 (el) 1998-12-15 2006-11-21 Εμβολιο πολλαπλων συστατικων που πepιλαμβανει τουλαχιστον δυο αντιγονα απο haemophilus influenzae για την προστασια εναντι νοσησης

Country Status (14)

Country Link
US (3) US6974581B1 (el)
EP (1) EP1140158B2 (el)
JP (1) JP4105393B2 (el)
AT (1) ATE339221T1 (el)
AU (1) AU772882B2 (el)
CA (1) CA2355466C (el)
CY (1) CY1106252T1 (el)
DE (1) DE69933237T3 (el)
DK (1) DK1140158T4 (el)
ES (1) ES2272086T5 (el)
NZ (1) NZ512679A (el)
PT (1) PT1140158E (el)
SI (1) SI1140158T2 (el)
WO (1) WO2000035477A2 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974581B1 (en) * 1998-12-15 2005-12-13 Aventis Pasteur Limited Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
US6342232B1 (en) 1999-03-03 2002-01-29 Aventis Pasteur Limited Multi-component vaccine comprising at least three antigens to protect against disease cased by Haemophilus influenzae
US7785609B1 (en) 1999-03-16 2010-08-31 Sanofi Pasteur Limited Recombinant Haemophilus influenzae adhesin proteins
US6391313B1 (en) * 1999-07-15 2002-05-21 Aventis Pasteur Limited Multi-component vaccine to protect against disease caused by Haemophilus influenzae and Moraxella catarrhalis
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
EP2773056B1 (en) 2013-03-01 2018-05-09 ADVA Optical Networking SE A method for tuning a tunable optical transmitter in an optical WDM transmission system and corresponding optical WDM transmission system
JP7382788B2 (ja) 2019-10-29 2023-11-17 株式会社ノダ 框組み建具

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US320942A (en) * 1885-06-30 Stone-dressing machine
US6103243A (en) * 1985-05-15 2000-08-15 Biotechnology Australia Pty, Ltd Oral vaccines
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
GB9205704D0 (en) * 1992-03-16 1992-04-29 Connaught Lab High molecular weight membrane proteins of non-typeable haemophilus
JP3626996B2 (ja) * 1992-05-23 2005-03-09 グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン
US5977336A (en) * 1993-03-16 1999-11-02 St. Louis University High molecular weight surface proteins of non-typeable haemophilus
US5770213A (en) * 1994-05-05 1998-06-23 American Cyanamid Company Purified nontypable haemophilus influenzae P5 protein as a vaccine for nontypable haemophilus influenzae infection
US5506139A (en) * 1994-07-21 1996-04-09 Connaught Laboratories Limited Analog of haemophilus Hin47 with reduced protease activity
NZ291750A (en) * 1994-07-21 1997-10-24 Connaught Lab Analogues of haemophilus influenzae hin47 protein with reduced protease activity
FR2734484B1 (fr) * 1995-05-24 1997-06-27 Pasteur Merieux Serums Vacc Composition vaccinale liquide et procede de fabrication
US5750116A (en) * 1995-06-02 1998-05-12 Bactex, Inc. Haemophilus influenzae pilus vaccines
US6974581B1 (en) * 1998-12-15 2005-12-13 Aventis Pasteur Limited Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease

Also Published As

Publication number Publication date
DE69933237T3 (de) 2011-03-03
DK1140158T4 (da) 2010-08-23
US20080286303A1 (en) 2008-11-20
DK1140158T3 (da) 2007-01-22
DE69933237T2 (de) 2007-04-12
ATE339221T1 (de) 2006-10-15
ES2272086T5 (es) 2010-11-29
DE69933237D1 (de) 2006-10-26
US6974581B1 (en) 2005-12-13
SI1140158T1 (sl) 2007-02-28
AU1543900A (en) 2000-07-03
EP1140158B2 (en) 2010-07-28
SI1140158T2 (sl) 2010-10-29
PT1140158E (pt) 2007-01-31
CA2355466A1 (en) 2000-06-22
NZ512679A (en) 2003-08-29
EP1140158B1 (en) 2006-09-13
CA2355466C (en) 2009-09-08
WO2000035477A2 (en) 2000-06-22
AU772882B2 (en) 2004-05-13
US20050118189A1 (en) 2005-06-02
WO2000035477A3 (en) 2000-10-26
EP1140158A2 (en) 2001-10-10
ES2272086T3 (es) 2007-04-16
JP4105393B2 (ja) 2008-06-25
JP2002532433A (ja) 2002-10-02

Similar Documents

Publication Publication Date Title
CY1106252T1 (el) Εμβολιο πολλαπλων συστατικων που πepιλαμβανει τουλαχιστον δυο αντιγονα απο haemophilus influenzae για την προστασια εναντι νοσησης
KR920014829A (ko) 뉴모코커스 다당류 결합체 백신
BR9906927A (pt) Proteìnas de neisseria meningitidis
BRPI0707154B8 (pt) composição de vacina
BR9306820A (pt) Conjugado de um antígeno fracamente imunogênico e um veículo peptideo sintetico vacina processos para melhorar a imunogenicidade de uma molecula de antigeno fracamente imunogenico e para imunizar um hospedeiro mamífero
DK0427347T3 (da) Syntetiske peptider, der kan anvendes som universelle bærere til fremstilling af immunogene konjugater, og anvendelse deraf til udvikling af syntetiske vacciner
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
WO2000020027A3 (en) Methods for therapeutic vaccination
ATE557041T1 (de) Peptid-vakzinen gegen streptokokken der gruppe a
DK1149589T3 (da) Proteinadjuvanser
WO1998046725A3 (en) Attenuated, invasive vaccines against fish pathogens
CY1105010T1 (el) Πεπτιδια που λαμβανονται απο τη συνδεση (g) πρωτεϊνης του αναπνευστικου συνκυτιακου ιου
CY1107620T1 (el) Πολυ-συστατικο εμβολιο για την προστασια εναντι της παθησης που προκαλειται απο haemophilus influenzae and moraxella catarrhalis
WO2003065973A3 (en) Multivalent streptococcal vaccine compositions and methods for use
ATE302016T1 (de) Peptide, verwendet als träger in immunogenen konstrukten, die in der entwicklung synthetischer impfstoffe geeignet sind
ATE105189T1 (de) Haemophilus influenzae typ b polysaccharidaussermembranprotein-konjugat als impfstoff.
BR9709993A (pt) Vacina preparação de vacina composição processo para produção de uma preparação imugênica e preparação imugênica
WO2000051633A3 (en) MULTI-COMPONENT VACCINE COMPRISING AT LEAST THREE ANTIGENS TO PROTECT AGAINST DISEASE CAUSED BY $i(HAEMOPHILUS INFLUENZAE)
ATE471156T1 (de) Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi
WO2002004497A3 (en) Multiple antigenic peptides immunogenic against streptococcus pneumoniae
PL331792A1 (en) Aviadenovirus, nucleic acid sequence encoding an antigen determinant, host cell transformed by such sequence, antibody or immune serum reacting with such antigen determinant and vaccine against diseases associated with a novel adenovirus
PT1535928E (pt) Composições de vacina compreendendo proteínas omp85 de neisseria gonorrhoeae e neisseria meningitidis
Vermeulen et al. DNA encoding an Eimeria 200 kD antigen